Novel Long-Acting Injection Cuts Schizophrenia Relapse Novel Long-Acting Injection Cuts Schizophrenia Relapse

A novel risperidone formulation cuts relapse risk in schizophrenia, new research suggests; but experts wonder: will it help improve the field ' s"deplorably low" use of long-acting antipsychotics?Medscape Medical News
Source: Medscape Psychiatry Headlines - Category: Psychiatry Tags: Psychiatry News Source Type: news